EviCure
PrivateLast Round
Seed
May 15, 2023
Company Overview
EviCure is a biotechnology company that develops an artificial intelligence-driven platform for the production of extracellular vesicle-based therapies to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EviCure Comparables
Compare EviCure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vanquish Bio | 79% | |
| ExoVectory | 78% | |
| ILIAS Biologics Inc. | 77% | |
EviCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 15, 2023 |
Key People
Founding team and executive leadership
EviCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Peregrine Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2023
Peregrine Ventures led the Seed round.
EviCure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EviCure's valuation, stock price, and market status.